BELLICUM PHARMACEUTICALS, INC 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jul 6, 2017
Insider Transaction Report
Form 4
Musso Alan A
CFO and Treasurer
Transactions
- Award
Stock Option (right to buy)
2017-07-03+31,500→ 31,500 totalExercise: $11.70Exp: 2027-07-02→ Common Stock (31,500 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option vest and become exercisable on January 1, 2018, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.